Tags : Johnson&Johnson

Philogen Collaborates with Johnson&Johnson (J&J), Novartis and Celgene

Shots: Philogen collaborates with J&J to discover & develop therapies utilizing Philochem’s technology (a Swizz subsidiary of Philogen) for serious conditions Philogen signs a development and commercialization agreement with Celgene for novel immunomodulatory therapies Philogen collaborates with Novartis for the research and development of immunomodulatory candidates. In 2017 & 2016, Philogen also collaborated with Boehringer […]Read More